2025
SJR Q3
JCR Q4 · 1,1
65 matched articles
SCIE
Journal detail
Journal of Clinical Pharmacy and Therapeutics
- Publisher
- John Wiley and Sons Inc
- Country
- China · Asiatic Region
- Type
- journal
- ISSN
-
0269472713652710
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,537
- Quartile Q3
- H-Index 90
- Cites/doc 1,1
- Docs (3y) 411
- Cites (3y) 915
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 1,1
- 5Y JIF 2,3
- JCI 0,41
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Pharmacology Q3
- Pharmacology (medical) Q3
Areas
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q4 | 0,537 | 1,1 | 2,3 | 0,41 | Q3 | 90 |
| 2024 | Q3 | Q3 | 0,582 | 2 | 2,2 | 0,44 | Q3 | 85 |
| 2023 | Q2 | Q3 | 0,569 | 2,1 | 2,1 | 0,46 | Q3 | 85 |
| 2022 | Q2 | Q4 | 0,52 | 2 | 2,1 | 0,45 | Q3 | 85 |
| 2021 | Q2 | Q4 | 0,517 | 2,1 | 2,4 | 0,46 | Q3 | 85 |
| 2020 | Q2 | Q3 | 0,622 | 2,5 | 2,4 | 0,57 | Q3 | 85 |
| 2019 | Q2 | Q4 | 0,605 | 1,8 | 2 | 0,6 | Q3 | 85 |
| 2018 | — | Q3 | — | 2,2 | 2 | 0,59 | Q3 | — |
| 2017 | Q2 | Q4 | 0,722 | 1,7 | 1,8 | 0,58 | Q3 | 85 |
| 2016 | Q2 | Q3 | 0,669 | 1,7 | 1,9 | — | — | 85 |
| 2015 | Q2 | Q3 | 0,708 | 1,8 | 1,8 | — | — | 85 |
| 2014 | Q2 | Q3 | 0,738 | 1,7 | 1,7 | — | — | 85 |
| 2013 | Q2 | Q3 | 0,681 | 1,5 | 1,8 | — | — | 85 |
| 2012 | Q2 | Q3 | 0,69 | 2,1 | 1,9 | — | — | 85 |
| 2011 | Q2 | Q3 | 0,653 | 1,6 | 1,7 | — | — | 85 |
| 2010 | Q2 | Q3 | 0,664 | 1,6 | 1,8 | — | — | 85 |
| 2009 | — | Q3 | — | 1,7 | 1,7 | — | — | — |
| 2008 | — | Q3 | — | 1,8 | 1,6 | — | — | — |
| 2007 | — | Q3 | — | 1,4 | 1,4 | — | — | — |
| 2006 | — | Q4 | — | 1 | — | — | — | — |
| 2005 | — | Q3 | — | 1,2 | — | — | — | — |
| 2004 | — | Q4 | — | 1 | — | — | — | — |
| 2003 | — | Q3 | — | 1,2 | — | — | — | — |
| 2002 | — | Q3 | — | 1,3 | — | — | — | — |
| 2001 | — | Q3 | — | 1,2 | — | — | — | — |
| 2000 | — | Q3 | — | 0,9 | — | — | — | — |
| 1999 | — | Q4 | — | 0,4 | — | — | — | — |
| 1998 | — | Q4 | — | 0,5 | — | — | — | — |
| 1997 | — | Q4 | — | 0,4 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 312/356 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 232/352 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 210/354 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 218/278 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 224/279 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 196/276 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 208/271 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 167/267 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 202/261 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 188/257 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 163/255 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 171/255 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 173/256 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 140/261 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 177/261 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 166/252 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 157/237 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 140/219 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 143/205 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 159/199 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 141/193 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 143/187 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 125/185 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 108/188 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 107/186 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 122/181 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 156/175 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 136/178 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 143/157 |